These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6472569)

  • 21. Phosphorylation in vivo of four basic proteins of rat brain myelin.
    Agrawal HC; O'Connell K; Randle CL; Agrawal D
    Biochem J; 1982 Jan; 201(1):39-47. PubMed ID: 7082288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of transport and assembly of myelin proteins.
    Bizzozero OA; Soto EF; Pasquini JM
    Acta Physiol Pharmacol Latinoam; 1984; 34(2):111-22. PubMed ID: 6240910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain.
    Sato S; Quarles RH; Brady RO
    J Neurochem; 1982 Jul; 39(1):97-105. PubMed ID: 6177834
    [No Abstract]   [Full Text] [Related]  

  • 24. The breakdown of myelin-bound proteins by intra- and extracellular proteases.
    Marks N; Grynbaum A; Lajtha A
    Neurochem Res; 1976 Feb; 1(1):93-111. PubMed ID: 24271248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical properties and intracellular processing of lysosomal cathepsins B and H.
    Nishimura Y; Tsuji H; Kato K; Sato H; Amano J; Himeno M
    Biol Pharm Bull; 1995 Jun; 18(6):829-36. PubMed ID: 7550115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degraded myelin-associated glycoprotein (dMAG) formation from pure human brain myelin-associated glycoprotein (MAG) is not mediated by calpain or cathepsin L-like activities.
    Päiväläinen S; Suokas M; Lahti O; Heape AM
    J Neurochem; 2003 Feb; 84(3):533-45. PubMed ID: 12558973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo.
    Hashida S; Towatari T; Kominami E; Katunuma N
    J Biochem; 1980 Dec; 88(6):1805-11. PubMed ID: 7462205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of human myelin proteins during old age.
    Berlet HH; Volk B
    Mech Ageing Dev; 1980; 14(1-2):211-22. PubMed ID: 6163044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The turnover of myelin proteins in adult rat brain.
    Singh H; Jungalwala FB
    Int J Neurosci; 1979; 9(2):123-31. PubMed ID: 478750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro degradation of apo-, zinc-, and cadmium-metallothionein by cathepsins B, C, and D.
    McKim JM; Choudhuri S; Klaassen CD
    Toxicol Appl Pharmacol; 1992 Sep; 116(1):117-24. PubMed ID: 1529444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells.
    Falgueyret JP; Black WC; Cromlish W; Desmarais S; Lamontagne S; Mellon C; Riendeau D; Rodan S; Tawa P; Wesolowski G; Bass KE; Venkatraman S; Percival MD
    Anal Biochem; 2004 Dec; 335(2):218-27. PubMed ID: 15556560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species variants of cathepsin L and their immunological identification.
    Mason RW
    Biochem J; 1986 Nov; 240(1):285-8. PubMed ID: 2435279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degradation of myofibrillar proteins by cathepsins B and D.
    Schwartz W; Bird JW
    Biochem J; 1977 Dec; 167(3):811-20. PubMed ID: 23766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of thiol proteases in galactosialidosis.
    Takeda E; Kuroda Y; Toshima K; Naito E; Ito M; Miyao M; Kominami E; Katunuma N
    Clin Chim Acta; 1986 Mar; 155(2):109-15. PubMed ID: 3084137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro acylation of myelin PLP and DM-20 in the quaking mouse brain.
    Agrawal HC; Agrawal D; Yoshimura T; Benjamins JA
    Neurochem Res; 1987 Sep; 12(9):783-6. PubMed ID: 2444895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium-stimulated proteolysis in myelin: evidence for a Ca2+-activated neutral proteinase associated with purified myelin of rat CNS.
    Banik NL; McAlhaney WW; Hogan EL
    J Neurochem; 1985 Aug; 45(2):581-8. PubMed ID: 2409235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the behavior of SH-protease inhibitor of rat epidermis on cathepsins B and H.
    Ohtani O; Fukuyama K; Epstein WL
    Comp Biochem Physiol B; 1982; 73(2):231-3. PubMed ID: 7172623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis.
    Sato S; Quarles RH; Brady RO; Tourtellotte WW
    Ann Neurol; 1984 Mar; 15(3):264-7. PubMed ID: 6202231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new purification procedure of human kidney cathepsin H, its properties and kinetic data.
    Popović T; Brzin J; Kos J; Lenarcic B; Machleidt W; Ritonja A; Hanada K; Turk V
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():175-83. PubMed ID: 3202963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolipid DM-20 predominates over PLP in peripheral nervous system.
    Pham-Dinh D; Birling MC; Roussel G; Dautigny A; Nussbaum JL
    Neuroreport; 1991 Feb; 2(2):89-92. PubMed ID: 1715780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.